Key facts
- Notable investors include Gloucester Ventures, VLX Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for NetwoRx Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for NetwoRx Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NetwoRx Bio
Operator of decentralized biomedical data networks designed for collaborative research and clinical insight generation. The company facilitates secure data exchange across institutions, integrates multi-omics and patient-derived datasets, supports privacy-preserving analytics, enabling researchers, clinicians, and biotech developers to access interoperable resources that accelerate discovery, improve diagnostic precision, and foster scalable innovation in life sciences.
- Sector
- Healthcare
- HQ
- Tel Aviv, Israel
- Founded
- 2024
- Employees
- 5
- Website
- networx.bio/
- Ownership
- Privately Held (backing)
NetwoRx Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NetwoRx Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NetwoRx Bio in its N-PORT filings yet. We sweep new filings monthly.